XML 18 R11.htm IDEA: XBRL DOCUMENT
v3.24.3

Accrued and Other Current Liabilities | 9 Months Ended
--- | ---
Sep. 30, 2024
Accounts Payable and Accrued Liabilities, Current [Abstract] |
Accrued and Other Current Liabilities | 3. Accrued and Other Current Liabilities Accrued and other current liabilities consist of the following (in thousands):
|  | September 30, 2024 |  |  | December 31, 2023 |
Accrued salaries and benefits |  | $ | 5,037 |  |  | $ | 6,078 |
Accrued manufacturing and research & development costs |  |  | 2,626 |  |  |  | 8,662 |
Accrued clinical trial and related costs |  |  | 2,137 |  |  |  | 2,701 |
Accrued legal fees and professional fees |  |  | 429 |  |  |  | 196 |
Accrued other liabilities |  |  | 343 |  |  |  | 714 |
Total accrued and other current liabilities |  | $ | 10,572 |  |  | $ | 18,351 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration